BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fazio N. Watch and wait policy in advanced neuroendocrine tumors: What does it mean? World J Clin Oncol 2017; 8(2): 96-99 [PMID: 28439490 DOI: 10.5306/wjco.v8.i2.96]
URL: https://www.wjgnet.com/2218-4333/full/v8/i2/96.htm
Number Citing Articles
Jingjing Zhang, Qingxing Liu, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Richard P. Baum. Prognostic Value of 18F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide TherapyJournal of Nuclear Medicine 2020; 61(11): 1560 doi: 10.2967/jnumed.119.241414
Mirco Bartolomei, Alfredo Berruti, Massimo Falconi, Nicola Fazio, Diego Ferone, Secondo Lastoria, Giovanni Pappagallo, Ettore Seregni, Annibale Versari. Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus ExerciseCancers 2022; 14(10): 2501 doi: 10.3390/cancers14102501
Jaume Capdevila, Jorge Hernando, Santiago Perez-Hoyos, Alejandro Roman-Gonzalez, Enrique Grande. Meta-Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine TumorsThe Oncologist 2019; 24(12): e1315 doi: 10.1634/theoncologist.2018-0675